1 Menzies Institute for Medical Research, University of Tasmania, Australia.
2 School of Medicine, University of Tasmania, Australia.
Eur J Prev Cardiol. 2017 Dec;24(18):1967-1978. doi: 10.1177/2047487317724008. Epub 2017 Aug 1.
Introduction The benefits of alcohol consumption for cardiovascular and metabolic health may have been overstated due to inappropriate comparisons with abstainers and inadequate control for confounding factors including physical activity and mental health. We examined alcohol consumption and cardio-metabolic health in a cohort of young Australian adults overcoming these limitations. Methods Cross-sectional data of a cohort of 2200 participants (age range 25-36 years) from the 2004-06 Childhood Determinants of Adult Health were used. Alcohol consumption was assessed from questionnaire and cardio-metabolic risk factors were measured in clinics. Linear and log binomial regression were used to examine total alcohol consumption (categories: none 0 g/day; light >0-10 g/day [reference]; moderate >10-20 g/day; heavy >20-30 g/day; very heavy >30 g/day) against dichotomous metabolic syndrome and its components: waist circumference, triglycerides, high-density lipoprotein cholesterol, blood pressure and glucose. Covariates included socio-demographics, smoking, diet, physical activity, fitness, depression and anxiety. Results Of the 2220 participants (48% males, mean (standard deviation) age 29.5 (2.5) years), most were classified in the 'light drinking' group (54.2%), less were in the 'non-drinking' (13.2%), 'heavy' (5.2%) or 'very heavy' (5.5%) drinking groups. Only moderate drinking was associated with a significantly lower prevalence of metabolic syndrome (prevalence ratio = 0.64, p < 0.05) compared with light drinking. Higher levels of alcohol consumption were associated with higher high-density lipoprotein cholesterol (β = 0.05, p < 0.001). Very heavy compared to light drinkers had higher systolic (β = 3.01 mm Hg, p < 0.01) and diastolic (β = 2.07 mm Hg, p < 0.05) blood pressure. Conclusion Moderate alcohol consumption was associated with a lower prevalence of MetS, and more favourable levels of lipids but not glucose or blood pressure even when compared to light consumption and with account for a range of confounding factors.
介绍
由于与不饮酒者的不适当比较以及对包括身体活动和心理健康在内的混杂因素的控制不足,饮酒对心血管和代谢健康的益处可能被夸大了。我们在克服这些局限性的情况下,在澳大利亚年轻成年人队列中研究了饮酒与心脏代谢健康之间的关系。
方法
使用 2004-06 年儿童期成人健康决定因素队列中 2200 名参与者(年龄范围 25-36 岁)的横断面数据。从问卷调查中评估饮酒量,并在诊所中测量心脏代谢风险因素。使用线性和对数二项式回归检查总饮酒量(类别:无 0g/天;轻度 >0-10g/天[参考];中度 >10-20g/天;重度 >20-30g/天;重度 >30g/天)与二元代谢综合征及其成分:腰围、甘油三酯、高密度脂蛋白胆固醇、血压和血糖。协变量包括社会人口统计学、吸烟、饮食、身体活动、健康状况、抑郁和焦虑。
结果
在 2220 名参与者中(48%为男性,平均(标准差)年龄 29.5(2.5)岁),大多数参与者被归类为“轻度饮酒”组(54.2%),较少的参与者为“非饮酒”组(13.2%)、“重度”(5.2%)或“重度”(5.5%)饮酒组。只有中度饮酒与代谢综合征的患病率显著降低相关(患病率比=0.64,p<0.05),与轻度饮酒相比。较高的饮酒水平与较高的高密度脂蛋白胆固醇相关(β=0.05,p<0.001)。与轻度饮酒者相比,重度饮酒者的收缩压(β=3.01mmHg,p<0.01)和舒张压(β=2.07mmHg,p<0.05)更高。
结论
中度饮酒与代谢综合征的患病率较低以及血脂水平更有利相关,但与轻饮酒相比,血糖或血压没有差异,即使与轻饮酒相比,并考虑到一系列混杂因素。